Results 31 to 40 of about 45,519 (269)

Case Report: Colchicine Toxicokinetic Analysis in a Poisoned Child Requiring Extracorporeal Life Support

open access: yesFrontiers in Pediatrics, 2021
Colchicine poisoning is associated with a poor prognosis, especially when leading to shock and multi-organ failure, and management is limited to supportive care, including multiple-dose activated charcoal.
Maria Pérez Marín   +9 more
doaj   +1 more source

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
Discovering of new anticancer agents with potential activity against tubulin polymerisation is still a promising approach. Colchicine binding site inhibitors are the most relevant anti-tubulin polymerisation agents.
Mohamed Hagras   +5 more
semanticscholar   +1 more source

In silico study of colchicine resistance molecular mechanisms caused by tubulin structural polymorphism.

open access: yesPLoS ONE, 2019
Starting from 1972, colchicine is known as the most useful drug for prevention of familial Mediterranean fever attacks. However, some patients do not respond to colchicine treatment, even taken in high doses.
Harutyun Sahakyan   +4 more
doaj   +1 more source

Biorhizome: A Biosynthetic Platform for Colchicine Biomanufacturing

open access: yesFrontiers in Plant Science, 2017
Colchicine is one of the oldest plant-based medicines used to treat gout and one of the most important alkaloid-based antimitotic drugs with anticancer potential, which is commercially extracted from Gloriosa superba.
Ganapathy Sivakumar   +2 more
doaj   +1 more source

Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial

open access: yesBMC Cardiovascular Disorders, 2021
Background Cardiovascular disease in particular acute coronary syndrome (ACS) is remained one of the most cause of morbidity and mortality, annually.
Mehdi Akrami   +6 more
semanticscholar   +1 more source

Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial

open access: yesEuropean Stroke Journal, 2021
Background Inflammation contributes to unstable atherosclerotic plaque and stroke. In randomised trials in patients with coronary disease, canukinumab (an interleukin-1B antagonist) and colchicine (a tubulin inhibitor with pleiotropic anti-inflammatory ...
P. Kelly   +24 more
semanticscholar   +1 more source

Clinically acceptable colchicine concentrations have potential for the palliative treatment of human cholangiocarcinoma

open access: yesKaohsiung Journal of Medical Sciences, 2015
Microtubules are an ideal target for anticancer drugs because of their essential role in mitosis. Colchicine is a microtubule destabilizer. Whether the clinically acceptable colchicine concentrations had anticancer effects on human cholangiocarcinoma ...
Chun-Chieh Wu   +3 more
doaj   +1 more source

Successfully Treated Severe Colchicine Intoxication in an Adolescent

open access: yesTürk Yoğun Bakim Derneği Dergisi, 2022
The contain is extracted from the autumn crocus plant, colchicine that an anti-inflammatory drug. The use of colchicine impairs mobilization and activation of neutrophil and supporting treating from some rheumatological diseases especially in childhood ...
Hatice Feray Arı   +2 more
doaj   +1 more source

Reducing length of hospital stay with colchicine

open access: yesJournal of Infection in Developing Countries, 2022
Introduction: Colchicine is an ancient agent with well-known anti-inflammatory effects and commonly used in treatment of hyperinflammatory conditions.
Özlem Karakaş   +10 more
doaj   +1 more source

Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis

open access: yesClinical and Experimental Pharmacology and Physiology, 2021
Currently, there is no widely acceptable and proven effective treatment for coronavirus disease 2019 (COVID‐19). Colchicine has been shown to offer a benefit in reducing the inflammation in several inflammatory diseases.
T. Hariyanto   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy